Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared a post on X about a paper he co-authored with colleagues published in ASCO Daily News:
“Hot off the press.
Just published on ASCO Daily News.
Editorial Article by our team, Mayo Clinic Comprehensive Cancer Center on:
MARIPOSA trial and latest developments in the Treatment of EGFR+ non-small cell lung cancer (NSCLC).
Very proud of outstanding 1st author/mentee, chief fellow Reema Tawfiq, and excited to co-author first article with my amazing friend/colleague and new chair Vamsi Velcheti.”
Title: The Butterfly Effect: Rethinking First-Line Therapy in Advanced EGFR-Mutant NSCLC After MARIPOSA
Authors: Reema Tawfiq, Rami Manochakian, Vamsi Velcheti
You can read the Full Article in ASCO Daily News.
More posts featuring Rami Manochakian.
